| Q64110089 | A comprehensive overview of mitochondrial DNA 4977-bp deletion in cancer studies |
| Q36915964 | A message emerging from development: the repression of mitochondrial beta-F1-ATPase expression in cancer. |
| Q29547303 | A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine |
| Q25257853 | A novel approach for rapid screening of mitochondrial D310 polymorphism |
| Q82023250 | A novel mitochondrial heteroplasmic C13806A point mutation associated with Iranian Friedreich's ataxia |
| Q24811339 | Absence of pathogenic mitochondrial DNA mutations in mouse brain tumors |
| Q35490449 | Alcohol consumption and breast tumor mitochondrial DNA mutations. |
| Q37710405 | Altered Mitochondrial Signalling and Metabolism in Cancer |
| Q37126201 | Analysis association between mitochondrial genome instability and xenobiotic metabolizing genes in human breast cancer. |
| Q34483868 | Analysis of gene alterations of mitochondrial DNA D-loop regions to determine breast cancer clonality |
| Q34713989 | Analysis of mitochondrial ND1 gene in human colorectal cancer |
| Q37098102 | Association of mitochondrial DNA displacement loop (CA)n dinucleotide repeat polymorphism with breast cancer risk and survival among Chinese women |
| Q36743644 | Associations between cigarette smoking and mitochondrial DNA abnormalities in buccal cells |
| Q37099852 | Biological contexts for DNA charge transport chemistry |
| Q93007886 | Cause or casualty: The role of mitochondrial DNA in aging and age-associated disease |
| Q42275003 | Changes in mitochondrial DNA alter expression of nuclear encoded genes associated with tumorigenesis |
| Q33278836 | Clinical implications and utility of field cancerization |
| Q41774162 | Common mitochondrial DNA mutations generated through DNA-mediated charge transport |
| Q24804325 | Control region mutations and the 'common deletion' are frequent in the mitochondrial DNA of patients with esophageal squamous cell carcinoma |
| Q37327729 | Correlational study on mitochondrial DNA mutations as potential risk factors in breast cancer |
| Q28487884 | Crosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways |
| Q46796420 | D-loop somatic mutations and ∼5 kb "common" deletion in mitochondrial DNA: important molecular markers to distinguish oral precancer and cancer |
| Q33985766 | DNA-mediated charge transport in redox sensing and signaling |
| Q33985107 | Do alterations in mitochondrial DNA play a role in breast carcinogenesis? |
| Q49307514 | Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells |
| Q34990451 | Electric field driven torque in ATP synthase |
| Q38632920 | Estrogen potentiates reactive oxygen species (ROS) tolerance to initiate carcinogenesis and promote cancer malignant transformation |
| Q84417029 | Evaluating mitochondrial DNA in patients with breast cancer and benign breast disease |
| Q94453395 | Evaluation of non-coding region sequence variants and mitochondrial haplogroups as potential biomarkers of sporadic breast cancer in individuals of Sri Lankan Sinhalese ethnicity |
| Q24674610 | Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck |
| Q88489096 | Frequency of pathogenic germline mutations in cancer susceptibility genes in breast cancer patients |
| Q46633781 | High-performance detection of somatic D-loop mutation in urothelial cell carcinoma patients by polymorphism ratio sequencing |
| Q87107302 | Identification of sequence polymorphisms in the mitochondrial displacement loop as risk factors for sporadic and familial breast cancer |
| Q37521873 | Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis |
| Q24791429 | Is cumulative frequency of mitochondrial DNA variants a biomarker for colorectal tumor progression? |
| Q37908233 | Metabolic alterations in cancer cells and therapeutic implications |
| Q47335770 | Metabolic control analysis of cellular respiration in situ in intraoperational samples of human breast cancer |
| Q42743208 | Metal Complexes for DNA-Mediated Charge Transport |
| Q58984147 | Mitochondrial D-loop and Cytochrome Oxidase C subunit I polymorphisms among the breast cancer patients of Mizoram, Northeast India |
| Q54261210 | Mitochondrial D310 instability in Asian Indian breast cancer patients. |
| Q36388046 | Mitochondrial DNA as a potential tool for early cancer detection |
| Q35418164 | Mitochondrial DNA content varies with pathological characteristics of breast cancer |
| Q64278542 | Mitochondrial DNA deletions in patients with esophagitis, Barrett’s esophagus, esophageal adenocarcinoma and squamous cell carcinoma |
| Q37139830 | Mitochondrial DNA instability and metabolic shift in human cancers. |
| Q37477802 | Mitochondrial DNA mutations and breast tumorigenesis |
| Q36373045 | Mitochondrial DNA mutations in human neoplasia |
| Q43200104 | Mitochondrial DNA mutations in renal cell carcinomas revealed no general impact on energy metabolism |
| Q35629197 | Mitochondrial DNA sequence variants in epithelial ovarian tumor subtypes and stages |
| Q30357800 | Mitochondrial NADH dehydrogenase polymorphisms are associated with breast cancer in Poland. |
| Q60907386 | Mitochondrial RNA Expression and Single Nucleotide Variants in Association with Clinical Parameters in Primary Breast Cancers |
| Q34826613 | Mitochondrial common deletion, a potential biomarker for cancer occurrence, is selected against in cancer background: a meta-analysis of 38 studies |
| Q24799964 | Mitochondrial defects in cancer |
| Q37455446 | Mitochondrial dysfunction in human breast cancer cells and their transmitochondrial cybrids |
| Q34345846 | Mitochondrial haplogroups and polymorphisms reveal no association with sporadic prostate cancer in a southern European population |
| Q33521198 | Mitochondrial mutations in adenoid cystic carcinoma of the salivary glands |
| Q48033166 | Mitochondrial mutations in human cancer: Curation of translation |
| Q37785514 | Molecular genetics of mitochondrial disorders |
| Q92082570 | Mutations in the ND2 Subunit of Mitochondrial Complex I Are Sufficient to Confer Increased Tumorigenic and Metastatic Potential to Cancer Cells |
| Q37485069 | Mutations in the mitochondrial DNA D-loop region and breast cancer risk |
| Q37219476 | Novel DNA mismatch-repair activity involving YB-1 in human mitochondria |
| Q35087229 | Novel HPMA copolymer-bound constructs for combined tumor and mitochondrial targeting |
| Q53380585 | Novel heteroplasmic frameshift and missense somatic mitochondrial DNA mutations in oral cancer of betel quid chewers |
| Q36496286 | Nuclear and mitochondrial DNA microsatellite instability in hepatocellular carcinoma in Chinese. |
| Q28393187 | Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidence |
| Q39226473 | Part II. Mitochondrial mutational status of high nitric oxide adapted cell line BT-20 (BT-20-HNO) as it relates to human primary breast tumors |
| Q24815938 | Possibility of selection against mtDNA mutations in tumors |
| Q30155975 | Post-transcriptional regulation of the mitochondrial H+-ATP synthase: A key regulator of the metabolic phenotype in cancer |
| Q26784413 | Reactive oxygen species, nutrition, hypoxia and diseases: Problems solved? |
| Q59807435 | Reduced Levels of ATP Synthase Subunit ATP5F1A Correlate with Earlier-Onset Prostate Cancer |
| Q35181094 | Review: mitochondrial defects in breast cancer |
| Q37382322 | Sequence-length variation of mtDNA HVS-I C-stretch in Chinese ethnic groups |
| Q24547869 | Significance of somatic mutations and content alteration of mitochondrial DNA in esophageal cancer |
| Q37697553 | Somatic alterations in mitochondrial DNA and mitochondrial dysfunction in gastric cancer progression |
| Q31048075 | Somatic mitochondrial DNA mutations in cancer escape purifying selection and high pathogenicity mutations lead to the oncocytic phenotype: pathogenicity analysis of reported somatic mtDNA mutations in tumors |
| Q51740135 | Targeting mitochondria as therapeutic strategy for metabolic disorders. |
| Q37617228 | The mitochondrial ATPase6 gene is more susceptible to mutation than the ATPase8 gene in breast cancer patients. |
| Q34299435 | Tipping the balance in the powerhouse of the cell to "protect" colorectal cancer |
| Q33955150 | Uncovering the profile of somatic mtDNA mutations in Chinese colorectal cancer patients |